BUZZ-U.S. STOCKS ON THE MOVE-Sarepta, Sprint, KaloBios, Mentor Graphics

Fri Nov 20, 2015 10:22am EST
Email This Article |
Share This Article
  • Facebook
  • LinkedIn
  • Twitter
| Print This Article | Single Page
[-] Text [+]

(For faster updates on individual market-movers, Eikon users please use search string "STXBZ US"; for the Day Ahead newsletter,; for the Morning News Call newsletter, U.S. stock indexes rose on Friday and were on track for their best weekly performance since October. The Dow Jones industrial average was up 0.96 percent at 17,903.55, the S&P 500 was up 0.69 percent at 2,095.66 and the Nasdaq Composite was up 0.64 percent at 5,106.267.

** BIOMARIN PHARMACEUTICAL INC, $98.595, -4.38 pct

** SAREPTA THERAPEUTICS INC, $32.9017, +26.21 pct

** PTC THERAPEUTICS INC, $28.5, -5.38 pct

U.S. Food and Drug Administration staff reviewers said clinical data to date did not merit approving the drug developer's muscle-wasting disorder drug.

Shares of Sarepta, which is developing rival product for DMD, rose. Shares of PTC, whose experimental DMD drug has also failed a late-stage study, fell.

** SPRINT CORP, $3.81, -5.93 pct   Continued...